Prevalence and clinical characteristics of obsessive-compulsive symptoms associated with atypical antipsychotics

Journal of Clinical Psychopharmacology

Volumn 27, Issue 6, 2007, Pages 712-713

  Lim, Meerae ^a   Park, Dong Yeon ^a   Kwon, Jun Soo ^b   Joo, Yeon Ho ^c   Hong, Kyung Sue ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; NEUROLEPTIC AGENT;

ADULT; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; CHEMICALLY INDUCED DISORDER; KOREA; PREVALENCE;

ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; KOREA; MALE; OBSESSIVE-COMPULSIVE DISORDER; PREVALENCE; SCHIZOPHRENIA;

EID: 39649088289     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31815a584c     Document Type: Letter

References (13)

1. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437-441.
2. Poyurovsky M, Hramenkov S, Isakov V, et al. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res. 2001;102:49-57.
3. Byerly M, Goodman W, Acholonu W, et al. Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophr Res. 2005;76:309-316.
4. Kayahan B, Ozturk O, Veznedaroglu B, et al. Obsessive-compulsive symptoms in schizophrenia: prevalence and clinical correlates. Psychiatry Clin Neurosci. 2005;59:291-295.
5. Lykouras L, Alevizos B, Michalopoulou P, et al. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:333-346.
6. Baker RW, Chengappa KN, Baird JW, et al. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53:439-442.
7. de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry. 1999;60:364-365.
8. Ertugrul A, Anil Yagcioglu AE, Eni N, et al. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients. Psychiatry Clin Neurosci. 2005;59:219-222.
9. Hahn OS, Ahn JH, Song SH, et al. Development of Korean version of Structured Clinical Interview Schedule for DSM-IV Axis I Disorder: interrater reliability. J Korean Neuropsychiatr Assoc. 2000;39:362-372.
10. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989;46:1012-1016.
11. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976:218-222.
12. Ha TH, Youn T, Rho KS, et al. Symptom dimensions of obsessive-compulsive disorder and their relation to comorbid personality pathology. J Korean Neuropsychiatr Assoc. 2004;43:46-53.
13. Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs. 2004;18:989-1010.